help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2009.080685 on December 30, 2008

Published online before print December 30, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2009.080685v1
174/2/647    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bari, R.
Right arrow Articles by Zhang, X. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bari, R.
Right arrow Articles by Zhang, X. A.
(American Journal of Pathology. 2009;174:647-660.)
© 2009 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2009.080685

Transmembrane Interactions Are Needed for KAI1/CD82-Mediated Suppression of Cancer Invasion and Metastasis

Rafijul Bari*, Yanhui H. Zhang*, Feng Zhang*, Nick X. Wang{dagger}, Christopher S. Stipp{ddagger}, Jie J. Zheng{dagger} and Xin A. Zhang*

From the Vascular Biology Center, Center for Cancer Research, and Departments of Medicine and Molecular Science,* University of Tennessee Health Science Center, Memphis, Tennessee; the Department of Structural Biology,{dagger} St. Jude Children’s Research Hospital, Memphis, Tennessee; and the Department of Biological Sciences,{ddagger} University of Iowa, Iowa City, Iowa

In transmembrane (TM) domains, tetraspanin KAI1/CD82 contains an Asn, a Gln, and a Glu polar residue. A mutation of all three polar residues largely disrupts the migration-, invasion-, and metastasis-suppressive activities of KAI1/CD82. Notably, KAI1/CD82 inhibits the formation of microprotrusions and the release of microvesicles, while the mutation disrupts these inhibitions, revealing the connections of microprotrusion and microvesicle to KAI1/CD82 function. The TM polar residues are needed for proper interactions between KAI1/CD82 and tetraspanins CD9 and CD151, which also regulate cell movement, but not for the association between KAI1/CD82 and {alpha}3β1 integrin. However, KAI1/CD82 still efficiently inhibits cell migration when either CD9 or CD151 is absent. Hence, KAI1/CD82 interacts with tetraspanin and integrin by different mechanisms and is unlikely to inhibit cell migration through its associated proteins. Moreover, without significantly affecting the glycosylation, homodimerization, and global folding of KAI1/CD82, the TM interactions maintain the conformational stability of KAI1/CD82, evidenced by the facts that the mutant is more sensitive to denaturation and less associable with tetraspanins and supported by the modeling analysis. Thus, the TM interactions mediated by these polar residues determine a conformation either in or near the tightly packed TM region and this conformation and/or its change are needed for the intrinsic activity of KAI1/CD82. In contrast to immense efforts to block the signaling of cancer progression, the perturbation of TM interactions may open a new avenue to prevent cancer invasion and metastasis.




This article has been cited by other articles:


Home page
 BloodHome page
R. Bari, T. Bell, W.-H. Leung, Q. P. Vong, W. K. Chan, N. Das Gupta, M. Holladay, B. Rooney, and W. Leung
Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245
Blood, December 10, 2009; 114(25): 5182 - 5190.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society for Investigative Pathology.